-
33 lots of hospital IV bags recalled over superpotency risk
Leiters Health has recalled 33 lots of IV bags filled with vancomycin, phenylephrine and fentanyl because the solutions might contain double the amount labeled. -
Merck to buy oncology drugmaker
Merck is acquiring South San Francisco-based Harpoon Therapeutics, an oncology drugmaker, for approximately $680 million. -
Cleveland Clinic appoints chief pharmacy officer
Lindsey Amerine, PharmD, was named chief pharmacy officer of Cleveland Clinic, effective Feb. 26. -
Johnson & Johnson to buy Ambrx in $2B deal
Johnson & Johnson plans to acquire Ambrx, a clinical-stage biotechnology company developing cancer treatments, for $1.9 billion. -
Drugmakers likely to copy Eli Lilly's Rx site for consumers, experts say
Eli Lilly's recent launch of a direct-to-consumer prescription drug website isn't expected to overthrow the pharmaceutical supply chain, but competitors are likely to take inspiration, CNBC reported Jan. 5. -
Bernie Sanders probes 4 drugmakers over inhaler prices
Sen. Bernie Sanders, I-Vt., and three other legislators on the Health, Education, Labor and Pensions Committee launched an investigation into inhalers, calling the prices "outrageous." -
Hospitals oppose Florida's plan to import drugs from Canada
Hospital pharmacies are criticizing Florida's plan to import drugs from Canada, arguing the idea undermines the pharmacist-patient relationship and fails to be a "real solution." -
Pictures don't cut it for medication safety: ISMP
Hospital pharmacy leaders should be vigilant about eradicating the syringe drawback method — and taking pictures during sterile compounding isn't enough, according to Rita Jew, PharmD, president of the Institute for Safe Medication Practices. -
4 Ozempic updates
Ozempic is facing increased competition from compounded versions and rival drugmakers, while potential side effects, including suicidal thoughts and hair loss, have spurred investigations into it and similar drugs. -
How a medication officer is 'improving safety at every step'
Stephen Hoang, MD, is the medication safety officer and a pediatric anesthesiologist at Children's Health System of Texas in Dallas. He recently connected with Becker's to share his team's biggest priority for 2024 and proudest accomplishment of 2023. -
Ozempic, Wegovy not tied to higher risk of suicidal thoughts: NIH study
Contrary to some anecdotal reports, a new study has found semaglutide — the active ingredient in blockbuster weight loss drugs Ozempic and Wegovy — is not linked to increased risks of suicidal thoughts. -
Florida becomes 1st state authorized by FDA to import meds from Canada
Florida has become the first state authorized by the FDA to import prescription drugs from Canada after the agency issued an approval of the Sunshine State's drug importation program Jan. 5. -
Eli Lilly to sell weight loss drugs directly to consumers; warns against 'cosmetic' usage
Eli Lilly has launched a new website for customers with migraines, obesity and diabetes to order prescription drugs directly from the manufacturer, including weight loss medications such as Zepbound. -
Walgreens ready to embrace 'Cost Plus' drug model, CEO says
Walgreens' new CEO Tim Wentworth says the pressure is on to develop new drug pricing models following a recent shift in the retail pharmacy market "to give patients the Cost Plus experience." -
FDA probes hair loss, other potential weight loss drug side effects
The FDA is looking into whether hair loss, aspiration and suicidal thoughts may be side effects of GLP-1 receptor agonists, a popular class of weight-loss drugs. -
A new weapon in the war against drug-resistant bacteria
Scientists have developed a new antibiotic, zosurabalpin, to attack a notoriously drug-resistant family of bacteria known as carbapenem-resistant Acinetobacter baumannii, or CRAB for short, which kills many of those it infects. -
Patient advocate Dr. Sidney Wolfe dies at 86
Sidney M. Wolfe, MD, who fought the FDA and pharmaceutical industry over high drug prices and dismissed health hazards for more than four decades, died at 86 years old, The New York Times reported. -
Pfizer to lay off 285 in New York
Pfizer will lay off more than a fourth of its employees at a New York facility, according to a WARN notice filed in the state. -
Colorado system turns to apprenticeships to ease tech shortage
Children's Hospital Colorado did not have the resources to pay pharmacy techs more or create a training program, so it established apprenticeships to solve the workforce shortage. -
Mark Cuban's drug company now sells 2K medications: What to know
Since launching in January 2021 with about 100 generics, Mark Cuban Cost Plus Drug Co. now offers more than 2,000 drugs, including about a dozen brand-name medications.
Page 13 of 50